For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
Viral infections continue to emerge and represent a serious threat to global public health, from SARS to H1N1 influenza to MERS. Yet none has caused the level of global devastation levied by the coronavirus. In fact, the long-term complications of COVID-19 on our healthcare system are just beginning to come into focus. Managing these complications will increase the demand for healthcare resources in the years to come and will elevate the need for novel therapies to manage them. This episode features Sy Pretorius, Parexel’s President, Clinical Development & Chief Medical Officer; Paul Bridges, Head of Consulting; and Ruggero Rossi, Vice President, Health Advances on how biopharmaceutical companies are preparing for COVID-19-related complications, the development of novel treatments to manage them, and future investments in vaccine development for infectious diseases so that we are better prepared for future pandemics.
Optimizing the Route to Regulatory Approval for a Novel Vaccine
Aug 18, 2023
New Infectious Disease, Vaccines Head brings clinical, philanthropic experience
Jun 20, 2023
Population diversity: important considerations in vaccine development
Jun 14, 2023
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Master Protocols from Design to Delivery
Sep 30, 2021
What COVID Taught Us About Focus, Innovation, and Leadership
Sep 24, 2021